Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA crawled date : 2022 - 06 - 03 save search
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: -0.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
IPHA | $2.425 -7.02% 2.7K
|
Health Technology
|
| O: 2.96%
H: 0.98%
C: -1.15%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
iph5201 pharma cancer phase 2
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.